Journal Club is an engaging and interactive web-based journal club for Pharmacists, Preceptors, Student Pharmacists on advanced pharmacy practice experiences (APPEs), and Pharmacy Residents.

Clostridiodes difficile infections are a significant burden to patients and the healthcare community. Novel approaches are being investigated to help mitigate relapses. This application-based continuing pharmacy education will review recent infectious disease literature with a unique spin. Join us to learn how machine based learning can inform clinical trials and the recent updates on C diff infections.

Upon successful completion of this application-based course, pharmacists and students should be able to:
1. Define the risks for Clostridiodes difficile infection relapse
2. Discuss the evidence in the guidelines for prevention of Clostridiodes difficile infection relapse
3. Discuss the results and conclusions of clinical trial
4. Define machine based learning and the relevance to clinical trial evaluation
5. Analyze the use of machine based learning within clinical trials

Aaron Burton, PharmD, BCPS
Assistant Professor
School of Pharmacy and Physician Assistant Studies
University of Saint Joseph

Dr. Burton does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course. 

CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read:

Caroff D, Menchaca B, Zhang Z, et al. Oral Vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. Infection Control & Hospital Epidemiology 2019 40, 662-667.

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Initial Release Date: September 9, 2020
Planned Expiration Date: September 9, 2023